abstract |
The present invention relates to pharmaceutical preparations of gemcitabine- [phenyl- (benzoxy-L-alaninyl)] - phosphate, which is a monophosphate (monophosphate) derivative of the well-known tumor drug gemcitabine. In particular, the invention relates to formulations comprising a polar aprotic solvent, preferably dimethylacetamide (DMA). The formulation comprising the solvent provides a therapeutically effective treatment of gemcitabine- [phenyl- (benzyloxy-L-alaninyl)] - phosphate. The invention also relates to a method of using the kit and the kit comprising the preparation. |